Primary Hyperoxaluria Type 1 Clinical Trials in London
2 recruitingLondon, United Kingdom
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
Phase 1/2 Study of ABO-101 in Primary Hyperoxaluria Type 1 (redePHine)
Primary Hyperoxaluria Type 1 (PH1)
Arbor Biotechnologies23 enrolled7 locationsNCT06839235
Recruiting
Phase 2
Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD
End Stage Renal DiseasePrimary Hyperoxaluria Type 1
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company28 enrolled18 locationsNCT04580420